REQUEST A DEMO
Total
USD $0.00
Search more companies

We Can Medicines Co., Ltd. (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: We Can Medicines Co., Ltd. Profile Updated: July 09, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

We Can Medicines Co., Ltd. is engaged in the wholesale, import and sale of healthcare products. The company's main products include western medicine, traditional Chinese medicine, health food and beauty care products. The company was established in 2000 and is headquartered in Taichung City, Taiwan.

Headquarters
20Th Floor-1, No. 925, Section 4Taiwan Avenue, Xitun Distr
Taichung City; Taichung City;

Contact Details: Purchase the We Can Medicines Co., Ltd. report to view the information.

Website: http://www.yourchance.com.tw

Basic Information
Total Employees:
Purchase the We Can Medicines Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the We Can Medicines Co., Ltd. report to view the information.
Financial Auditors:
Purchase the We Can Medicines Co., Ltd. report to view the information.
Incorporation Date:
April 13, 2000
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
51.2%
Purchase this report to view the information.
32.89%
Purchase this report to view the information.
0.37%
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after We Can Medicines Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
6.87%
Total operating revenue
7.95%
Operating profit (EBIT)
1.38%
EBITDA
3.67%
Net Profit (Loss) for the Period
-41.94%
Total assets
21.48%
Total equity
42.38%
Operating Profit Margin (ROS)
-0.07%
Net Profit Margin
-0.38%
Return on Equity (ROE)
-0.95%
Debt to Equity Ratio
93.32%
Quick Ratio
0.28%
Cash Ratio
0.13%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?